Johnson & Johnson (JNJ)
Sector: Healthcare
Industry: Pharmaceutical Preparations
Country: United States
Exchange: NYSE
Market cap: $651.20B
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Latest financial period: June 28, 2026
Filed with the SEC: July 23, 2026
Estimated earnings date: October 13, 2026
Profit #283 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 80.8% | 80.8% | 83.8% | 83.7% |
Growth #726 of 1484 companies
Payout #107 of 1484 companies
Safety #491 of 1484 companies
Price #929 of 1484 companies
